Show simple item record

Subcutaneous Immunoglobulin Therapy In The Chronic Management Of Myasthenia Gravis.

dc.contributor.authorAlfituri, Nadia Abdelsalam Omran
dc.date.accessioned2018-01-23T12:09:08Z
dc.date.available2018-01-23T12:09:08Z
dc.date.issued2017-02-21
dc.identifier.urihttp://repository.limu.edu.ly/handle/123456789/168
dc.description.abstractSubcutaneous immunoglobulin therapy has been recently researched and shown to be favorable and to have advantages over intravenous immunoglobulin therapy, in the chronic management of myasthenia gravis. This report aims to discuss the findings of research into this new long term therapy option for myasthenia gravis.en_US
dc.language.isoenen_US
dc.publisherFaculty of Basic Medical Science - Libyan International Medical Universityen_US
dc.rightsAttribution 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/us/*
dc.subjectSubcutaneous immunoglobulin therapyen_US
dc.titleSubcutaneous Immunoglobulin Therapy In The Chronic Management Of Myasthenia Gravis.en_US
dc.title.alternativeSubcutaneous immunoglobulin therapyen_US
dc.typeTechnical Reporten_US


Files in this item

Thumbnail
Name:
Subcutaneous Immunoglobulin ...
Size:
379.4Kb
Format:
PDF
Thumbnail
Name:
license_rdf
Size:
913bytes
Format:
application/rdf+xml

This item appears in the following Collection(s)

Show simple item record

Attribution 3.0 United States
Except where otherwise noted, this item's license is described as Attribution 3.0 United States